Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles

Experimental Eye Research

Volumn 116, Issue , 2013, Pages 161-168

  Nieto, Alejandra ^a   Hou, Huiyuan ^a   Sailor, Michael J ^a   Freeman, William R ^a   Cheng, Lingyun ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intravitreal porous silicon; Ocular drug delivery; Ocular silicon clearance; Rabbit eye

Indexed keywords

SILICIC ACID;

AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; BIOCOMPATIBILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; FLAME PHOTOMETRY; MEASUREMENT; MEMBRANE MICROPARTICLE; MICRODIALYSIS; PRIORITY JOURNAL; RABBIT; VITREOUS BODY;

INTRAVITREAL POROUS SILICON; OCULAR DRUG DELIVERY; OCULAR SILICON CLEARANCE; RABBIT EYE;

ANIMALS; AQUEOUS HUMOR; DRUG DELIVERY SYSTEMS; HALF-LIFE; INTRAVITREAL INJECTIONS; PARTICLE SIZE; POROSITY; RABBITS; RETINA; SILICON;

EID: 84884540152     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.09.001     Document Type: Article

References (33)

1. Anglin E.J., Cheng L., Freeman W.R., Sailor M.J. Porous silicon in drug delivery devices and materials. Adv. Drug Deliv. Rev. 2008, 60:1266-1277.
2. Araie M., Maurice D.M. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp. Eye Res. 1991, 52:27-39.
3. Becker B. The turnover of bromide in the rabbit eye. Arch. Ophthalmol. 1961, 65:837-839.
4. Bimbo L.M., Sarparanta M., Santos H.A., Airaksinen A.J., Mäkilä E., Laaksonen T., Peltonen L., Lehto V.-P., Hirvonen J., Salonen J. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010, 4:3023-3032.
5. Brinker C.J., Scherer G.W. Sol-gel Science: the Physics and Chemistry of Sol-gel Processing 1990, Academic Press, San Diego.
6. Brunauer S., Emmett P.H., Teller E. Adsorption of gases in multimolecular layers. J.Am. Chem. Soc. 1938, 60:309-319.
7. Chen H., Sun S., Li J., Du W., Zhao C., Hou J., Xu Y., Cheng L. Different intravitreal properties of three triamcinolone formulations and their possible impact on retina practice. Invest. Ophthalmol. Vis. Sci. 2013, 54:2178-2185.
8. Cheng L.Y., Hostetler K.Y., Lee J., Koh H.J., Beadle J.R., Bessho K., Toyoguchi M., Aldern K., Bovet J.M., Freeman W.R. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Invest. Ophthalmol. Vis. Sci. 2004, 45:4138-4144.
9. Cheng L., Anglin E., Cunin F., Kim D., Sailor M.J., Falkenstein I., Tammewar A., Freeman W.R. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br. J. Ophthalmol. 2008, 92:705-711.
10. Chhablani J., Nieto A., Hou H., Wu E.C., Freeman W.R., Sailor M.J., Cheng L. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system. Invest. Ophthalmol. Vis. Sci. 2013, 54:1268-1279. 10.1167/iovs.12-11172.
11. Collery P., Maymard I., Theophanides T., Khassanova L., Collery T. Metal Ions in Biology and Medicine 1998, John Libbey. Eurotext, Paris.
12. Davson H., Luck C.P. Acomparative study of the total carbon dioxide in the ocular fluids, cerebrospinal fluid, and plasma of some mammalian species. J.Physiol. 1956, 132:454-464.
13. Dyck K.V., Robberecht H., Cauwenbergh R.V., Deelstra H., Arnaud J., Willemyns L., Benijts F., Centeno J.A., Taylor H., Soares M.E., Bastos M.L., Ferreira M.A., D'Haese P.C., Lamberts L.V., Hoenig M., Knapp G., Lugowski S.J., Moens L., Riondato J., Grieken R.V., Claes M., Verheyen R., Clement L., Uytterhoeven M. Spectrometric determination of silicon in food and biological samples: an interlaboratory trial. J.Anal. At. Spectrom. 2000, 15:735-741.
14. Gregg S.J., Sing K.S.W. Adsorption, Surface Area, and Porosity 1982, Academic Press Inc., London. second ed.
15. Hauptkorn S., Pavel J., Seltner H. Determination of silicon in biological samples by ICP-OES after non-oxidative decomposition under alkaline conditions. Fresen J. Anal Chem. 2001, 370:246-250.
16. Iler R.K. The Chemistry of Silica 1979, John Wiley & Sons, New York.
17. Jurkic L.M., Cepanec I., Pavelic S.K., Pavelic K. Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: new perspectives for therapy. Nutr. Metab. 2013, 10.
18. Kashanian S., Harding F., Irani Y., Klebe S., Marshall K., Loni A., Canham L., Fan D.M., Williams K.A., Voelcker N.H., Coffer J.L. Evaluation of mesoporous silicon/polycaprolactone composites as ophthalmic implants. Acta Biomater. 2010, 6:3566-3572.
19. Kruk M., Jaroniec M. Relations between pore structure parameters and their implications for characterization of MCM-41 using Gas Adsorption and X-ray diffraction. Chem. Mater. 1999, 11:492-500.
20. Leoni L., Boiarski A., Desai T.A. Characterization of nanoporous membranes for immunoisolation: diffusion properties and tissue effects. Biomed. Microdevices 2002, 4:131-139.
21. Low S.P., Williams K.A., Canham L.T., Voelcker N.H. Evaluation of mammalian cell adhesion on surface-modified porous silicon. Biomaterials 2006, 27:4538-4546.
22. McMaster P.R., Macri F.J. The rate of aqueous humor formation in buphthalmic rabbit eyes. Invest. Ophthalmol. 1967, 6:84-87.
23. Mertz W. The essential trace-Elements. Science 1981, 213:1332-1338.
24. Moseley H., Foulds W.S., Allan D., Kyle P.M. Routes of clearance of radioactive water from the rabbit vitreous. Brit. J. Ophthalmol. 1984, 68:145-151.
25. Nan K.H., Sun S.M., Li Y.L., Qu J., Li G.X., Luo L., Chen H., Cheng L.Y. Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-tenon injection. Brit. J. Ophthalmol. 2010, 94:654-658.
26. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for invivo applications. Nat. Mater. 2009, 8:331-336.
27. Roberts N.B., Williams P. Silicon measurement in serum and urine by direct current plasma emission spectrometry. Clin. Chem. 1990, 36:1460-1465.
28. Salonen J., Kaukonen A.M., Hirvonen J., Lehto V.P. Mesoporous silicon in drug delivery applications. J.Pharm. Sci-US 2008, 97:632-653.
29. Thonissen M., Berger M.G. Multilayer structures of porous silicon. Properties of Porous Silicon 1997.
30. Veilleux-Lemieux D., Beaudry F., Hélie P., Vachon P. Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague-Dawley rats. Vet. Med. Res. Rep. 2012, 3:99-109.
31. Vincent G. Optical-properties of porous silicon superlattices. Appl. Phys. Lett. 1994, 64:2367-2369.
32. Wills N.K., Ramanujam V.M.S., Kalariya N., Lewis J.R., van Kuijk F.J.G.M. Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age, and gender. Exp. Eye Res. 2008, 87:80-88.
33. Wu E.C., Andrew J.S., Cheng L., Freeman W.R., Pearson L., Sailor M.J. Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials 2011, 32:1957-1966.